Prostate cancer and urinary incontinence
- PMID: 19615834
- DOI: 10.1016/j.maturitas.2009.06.005
Prostate cancer and urinary incontinence
Abstract
Prostate cancer is the third most common cancer worldwide and an increasing proportion of men are being diagnosed with localised disease. Urinary incontinence is uncommon in healthy men, but may develop as a result of curative treatment for prostate cancer. The optimal therapy remains undefined so the treatment associated morbidity is an important determinant in patient choice. Urinary incontinence may also develop from tumour progression during deferred treatment, sphincter involvement in advanced disease or surgery for symptomatic malignant bladder outlet obstruction. As urinary incontinence is known to have a significant impact on health related quality of life, we have reviewed the literature on incontinence related to prostate cancer and its treatment.
Similar articles
-
Quality of life in patients with localized prostate cancer.Urol Oncol. 2005 May-Jun;23(3):208-15. doi: 10.1016/j.urolonc.2005.03.003. Urol Oncol. 2005. PMID: 15907723 Review.
-
Quality of life in men with locally advanced adenocarcinoma of the prostate: an exploratory analysis using data from the CaPSURE database.J Urol. 2008 Dec;180(6):2409-13; discussion 2414. doi: 10.1016/j.juro.2008.08.079. Epub 2008 Oct 18. J Urol. 2008. PMID: 18930270
-
Quality of life for men with prostate cancer.Cancer Nurs. 2007 Jul-Aug;30(4):302-8. doi: 10.1097/01.NCC.0000281726.87490.f2. Cancer Nurs. 2007. PMID: 17666980 Review.
-
[Side effects and quality of life in prostate cancer following treatment].Nihon Rinsho. 2000 Jul;58 Suppl:437-45. Nihon Rinsho. 2000. PMID: 11022766 Review. Japanese. No abstract available.
-
Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.J Natl Cancer Inst. 2009 Jun 16;101(12):888-92. doi: 10.1093/jnci/djp114. Epub 2009 Jun 9. J Natl Cancer Inst. 2009. PMID: 19509365
Cited by
-
Patient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy.Br J Cancer. 2013 May 28;108(10):1964-70. doi: 10.1038/bjc.2013.180. Epub 2013 Apr 30. Br J Cancer. 2013. PMID: 23632483 Free PMC article.
-
Predictive value of microRNA-133a-3p for early urinary incontinence after radical prostatectomy for prostate cancer and its correlation with rehabilitation effects.Hereditas. 2025 May 11;162(1):75. doi: 10.1186/s41065-025-00443-2. Hereditas. 2025. PMID: 40350457 Free PMC article.
-
Potential Role of Exercise Induced Extracellular Vesicles in Prostate Cancer Suppression.Front Oncol. 2021 Sep 14;11:746040. doi: 10.3389/fonc.2021.746040. eCollection 2021. Front Oncol. 2021. PMID: 34595123 Free PMC article. Review.
-
Presentation, management, and outcomes of complications following prostate cancer therapy.Transl Androl Urol. 2014 Jun;3(2):150-5. doi: 10.3978/j.issn.2223-4683.2014.04.05. Transl Androl Urol. 2014. PMID: 26816763 Free PMC article.
-
Exosomal RNF157 mRNA from prostate cancer cells contributes to M2 macrophage polarization through destabilizing HDAC1.Front Oncol. 2022 Oct 3;12:1021270. doi: 10.3389/fonc.2022.1021270. eCollection 2022. Front Oncol. 2022. PMID: 36263220 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials